Among patients with ESR1 mutations, the median progression-free survival was 5.5 months with imlunestrant monotherapy and 3.8 months with standard care. Imlunestrant, given alone or in combination ...
DEXScreener data shows that over 45,000 wallets have bought the token, which had hit a market cap of $6.14 billion since launching at just after 9 pm UTC on Jan. 19. Meanwhile, Donald Trump’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback